Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
| Brand name | CHLORPROMAZINE HYDROCHLORIDE |
| Generic name | CHLORPROMAZINE HYDROCHLORIDE |
| Active ingredient(s) | CHLORPROMAZINE HYDROCHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 70710-1129-1 |
| Full product label | Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1129-1 |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide in the USA |
| Quantity | N/A |
| Recall initiated | 2025-09-03 |
| Report date | 2025-09-17 |
| Recall completed | — |
| Recall number | D-0630-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗